Home > Reports, Tools, & Publications > Use of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update

Use of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update

Pierre Ernst, Lisa M. Lix, Greg Carney, Nick Daneman, Matt Dahl, Tayler Dawn Scory, Daniel Dutton, Xue Feng, Donica Janzen, Vicki Ling, Devin Manning, Tarita Miller, Paul Ronksley, Audray St-Jean
Canada's Drug Agency
December 6, 2024

The publication aims to assess the impact of the risk-minimization measures applied in 2017 and comparing the current trends to fluoroquinolone use to those from a previous drug utilization study conducted by CNODES.

Citation

Ernst, P., Lix, L.M., Carney, G. Daneman, N., Dahl, M., Dawn-Scory, T., Dutton, D., Feng, X., Janzen, D. et al. Use of Oral Fluoroquinolones in Canada: A Drug Utilization Study Update (2024). https://www.cda-amc.ca/use-oral-fluoroquinolones-canada-drug-utilization-study-update

https://www.cda-amc.ca/use-oral-fluoroquinolones-canada-drug-utilization-study-update